TY - JOUR
T1 - Evaluation of a campaign to reduce consumption of sugar-sweetened beverages in New Jersey
AU - Bonnevie, Erika
AU - Morales, Orville
AU - Rosenberg, Sarah D.
AU - Goldbarg, Jaclyn
AU - Silver, Maggie
AU - Wartella, Ellen
AU - Smyser, Joe
N1 - Funding Information:
This work was supported by The Nicholson Foundation . The Nicholson Foundation did not have any involvement in study design, collection, analysis or interpretation of the data, the writing of the manuscript, or the decision to submit the manuscript for publication.
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/7
Y1 - 2020/7
N2 - Obesity is a leading cause of premature death in the U.S., in part due to consumption of sugar sweetened beverages (SSBs). In New Jersey, African Americans, Hispanics, and those of low income have the highest rates of SSB consumption. This study evaluates the impact of NJ Sugarfreed, a campaign designed to reduce sugar-sweetened beverage (SSB) consumption across New Jersey. From 12/1/17–9/30/18, we used a collective impact model to create targeted statewide campaigns that reduce SSB consumption among New Jersey residents, with an emphasis on African American and Hispanic low-income mothers/caregivers who are often gatekeepers to children's SSB consumption. Passaic County, New Jersey received a higher dose intervention. Messages were disseminated through social media, partner organizations, and community partnerships. Campaign impact was examined through evaluation surveys and analysis of beverage sales. Baseline and follow-up surveys (n = 800 baseline; n = 782 follow-up) showed positive trends toward decreased soda consumption and increased knowledge about SSBs. Passaic respondents showed a 5% decrease in those who consume 1+ soda per day, compared to a 1% decrease among New Jersey respondents. Analysis of overall SSB beverage sales showed the most pronounced decreases in Passaic (7% decrease) compared to New Jersey (6%). By drawing upon best practices in message development and the use of various platforms for dissemination, combined with community-based participation, we have provided more evidence to support the use of a collective impact model as a way of reducing unhealthy behaviors that impact health disparities.
AB - Obesity is a leading cause of premature death in the U.S., in part due to consumption of sugar sweetened beverages (SSBs). In New Jersey, African Americans, Hispanics, and those of low income have the highest rates of SSB consumption. This study evaluates the impact of NJ Sugarfreed, a campaign designed to reduce sugar-sweetened beverage (SSB) consumption across New Jersey. From 12/1/17–9/30/18, we used a collective impact model to create targeted statewide campaigns that reduce SSB consumption among New Jersey residents, with an emphasis on African American and Hispanic low-income mothers/caregivers who are often gatekeepers to children's SSB consumption. Passaic County, New Jersey received a higher dose intervention. Messages were disseminated through social media, partner organizations, and community partnerships. Campaign impact was examined through evaluation surveys and analysis of beverage sales. Baseline and follow-up surveys (n = 800 baseline; n = 782 follow-up) showed positive trends toward decreased soda consumption and increased knowledge about SSBs. Passaic respondents showed a 5% decrease in those who consume 1+ soda per day, compared to a 1% decrease among New Jersey respondents. Analysis of overall SSB beverage sales showed the most pronounced decreases in Passaic (7% decrease) compared to New Jersey (6%). By drawing upon best practices in message development and the use of various platforms for dissemination, combined with community-based participation, we have provided more evidence to support the use of a collective impact model as a way of reducing unhealthy behaviors that impact health disparities.
KW - Collective impact
KW - Community interventions
KW - Mass media campaigns
KW - Obesity prevention
UR - http://www.scopus.com/inward/record.url?scp=85084355105&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084355105&partnerID=8YFLogxK
U2 - 10.1016/j.ypmed.2020.106062
DO - 10.1016/j.ypmed.2020.106062
M3 - Article
C2 - 32205177
AN - SCOPUS:85084355105
SN - 0091-7435
VL - 136
JO - Preventive Medicine
JF - Preventive Medicine
M1 - 106062
ER -